NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.

RecruitingNA

Sponsor: Universitaire Ziekenhuizen KU Leuven

Conditions: Alzheimer's Disease (AD)

Interventions: ptau217

Countries: Belgium

The goal of this study is to determine how blood biomarker tests (ptau217 and ptau217/Aβ42) performed in primary care influence the patient trajectory in individuals with cognitive concerns. Participants will provide a blood sample for biomarker testing and undergo clinical assessments as part of diagnostic evaluation.

Eligibility overview

Sex: ALL

Age: 55 Years to 85 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients between 55 and 85 years old who consult their PCP due to concerns about their cognitive status.

Exclusion Criteria:

* Comorbidities that would interfere with study cooperation or interpretability of study results (for instance substance abuse or cardiac, renal or hepatic failure).
* Concomitant medications that would interfere with cognitive assessments.
* A prior diagnosis of AD and related disorders or other neurodegenerative disease.

Locations (1)

Leuven, Belgium